MYOD1 functions as a clock amplifier as well as a critical co-factor for downstream circadian gene expression in muscle

  1. Brian A Hodge
  2. Xiping Zhang
  3. Miguel A Gutierrez-Monreal
  4. Yi Cao
  5. David W Hammers
  6. Zizhen Yao
  7. Christopher A Wolff
  8. Ping Du
  9. Denise Kemler
  10. Andrew R Judge
  11. Karyn A Esser  Is a corresponding author
  1. University of Florida, United States
  2. Genentech Inc, United States
  3. Allen Institute for Brain Science, United States

Abstract

In the present study we show that the master myogenic regulatory factor, MYOD1, is a positive modulator of molecular clock amplitude and functions with the core clock factors for expression of clock-controlled genes in skeletal muscle. We demonstrate that MYOD1 directly regulates the expression and circadian amplitude of the positive core clock factor Bmal1. We identify a non-canonical E-box element in Bmal1 and demonstrate that is required for full MYOD1-responsiveness. Bimolecular fluorescence complementation assays demonstrate that MYOD1 colocalizes with both BMAL1 and CLOCK throughout myonuclei. We demonstrate that MYOD1 and BMAL1:CLOCK work in a synergistic fashion through a tandem E-box to regulate the expression and amplitude of the muscle specific clock-controlled gene, Titin-cap (Tcap). In conclusion, these findings reveal mechanistic roles for the muscle specific transcription factor MYOD1 in the regulation of molecular clock amplitude as well as synergistic regulation of clock-controlled genes in skeletal muscle.

Data availability

ChIP seq data for muscle with MyoD is deposited in GEO under accession code GSE122082.

The following data sets were generated

Article and author information

Author details

  1. Brian A Hodge

    Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  2. Xiping Zhang

    Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  3. Miguel A Gutierrez-Monreal

    Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  4. Yi Cao

    Department of Bioinformatics and Computational Biology, Genentech Inc, South San Francisco, United States
    Competing interests
    Yi Cao, Is affiliated with Genentech Inc.. The author has no other competing interests to declare.
  5. David W Hammers

    Department of Pharmacology and Therapeutics, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  6. Zizhen Yao

    Cell Types Program, Allen Institute for Brain Science, Seattle, United States
    Competing interests
    No competing interests declared.
  7. Christopher A Wolff

    Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  8. Ping Du

    Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  9. Denise Kemler

    Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  10. Andrew R Judge

    Department of Physical Therapy, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  11. Karyn A Esser

    Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
    For correspondence
    kaesser@ufl.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5791-1441

Funding

National Institutes of Health (R01AR066082)

  • Karyn A Esser

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Andrew Brack, University of California, San Francisco, United States

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (IACUC Study 201809136) of the University of Florida.

Version history

  1. Received: October 19, 2018
  2. Accepted: February 20, 2019
  3. Accepted Manuscript published: February 21, 2019 (version 1)
  4. Version of Record published: March 4, 2019 (version 2)

Copyright

© 2019, Hodge et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,659
    Page views
  • 517
    Downloads
  • 47
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Brian A Hodge
  2. Xiping Zhang
  3. Miguel A Gutierrez-Monreal
  4. Yi Cao
  5. David W Hammers
  6. Zizhen Yao
  7. Christopher A Wolff
  8. Ping Du
  9. Denise Kemler
  10. Andrew R Judge
  11. Karyn A Esser
(2019)
MYOD1 functions as a clock amplifier as well as a critical co-factor for downstream circadian gene expression in muscle
eLife 8:e43017.
https://doi.org/10.7554/eLife.43017

Share this article

https://doi.org/10.7554/eLife.43017

Further reading

    1. Cell Biology
    Kazuki Hanaoka, Kensuke Nishikawa ... Kouichi Funato
    Research Article

    Membrane contact sites (MCSs) are junctures that perform important roles including coordinating lipid metabolism. Previous studies have indicated that vacuolar fission/fusion processes are coupled with modifications in the membrane lipid composition. However, it has been still unclear whether MCS-mediated lipid metabolism controls the vacuolar morphology. Here, we report that deletion of tricalbins (Tcb1, Tcb2, and Tcb3), tethering proteins at endoplasmic reticulum (ER)–plasma membrane (PM) and ER–Golgi contact sites, alters fusion/fission dynamics and causes vacuolar fragmentation in the yeast Saccharomyces cerevisiae. In addition, we show that the sphingolipid precursor phytosphingosine (PHS) accumulates in tricalbin-deleted cells, triggering the vacuolar division. Detachment of the nucleus–vacuole junction (NVJ), an important contact site between the vacuole and the perinuclear ER, restored vacuolar morphology in both cells subjected to high exogenous PHS and Tcb3-deleted cells, supporting that PHS transport across the NVJ induces vacuole division. Thus, our results suggest that vacuolar morphology is maintained by MCSs through the metabolism of sphingolipids.

    1. Cell Biology
    2. Chromosomes and Gene Expression
    Monica Salinas-Pena, Elena Rebollo, Albert Jordan
    Research Article

    Histone H1 participates in chromatin condensation and regulates nuclear processes. Human somatic cells may contain up to seven histone H1 variants, although their functional heterogeneity is not fully understood. Here, we have profiled the differential nuclear distribution of the somatic H1 repertoire in human cells through imaging techniques including super-resolution microscopy. H1 variants exhibit characteristic distribution patterns in both interphase and mitosis. H1.2, H1.3, and H1.5 are universally enriched at the nuclear periphery in all cell lines analyzed and co-localize with compacted DNA. H1.0 shows a less pronounced peripheral localization, with apparent variability among different cell lines. On the other hand, H1.4 and H1X are distributed throughout the nucleus, being H1X universally enriched in high-GC regions and abundant in the nucleoli. Interestingly, H1.4 and H1.0 show a more peripheral distribution in cell lines lacking H1.3 and H1.5. The differential distribution patterns of H1 suggest specific functionalities in organizing lamina-associated domains or nucleolar activity, which is further supported by a distinct response of H1X or phosphorylated H1.4 to the inhibition of ribosomal DNA transcription. Moreover, H1 variants depletion affects chromatin structure in a variant-specific manner. Concretely, H1.2 knock-down, either alone or combined, triggers a global chromatin decompaction. Overall, imaging has allowed us to distinguish H1 variants distribution beyond the segregation in two groups denoted by previous ChIP-Seq determinations. Our results support H1 variants heterogeneity and suggest that variant-specific functionality can be shared between different cell types.